Andres Fontaine Nicola MD Mario Masrur Francisco Schlottmann MD MPH Reed Berger MD, PNS, DABOM Amber Pirzada Khaled Abdelhady Bianca Serafica Lily Zhang Thyroid Disease Risk in Tirzepatide Treated Patients Colleagues working in the obesity field, I invite you to read our latest article published in "Clinical Obesity" journal, in which we discuss about the potential risk of thyroid disease in patients treated with tirzepatide
GLP-1 microdosing schedule Microdosing schedules usually follow the same weekly cadence as standard GLP-1 medications, just at lower doses
Liraglutide and sermorelin peptide are both peptides, but serve different functions
Regarding renal health, the medication itself is not nephrotoxic, but the side effects (vomiting, diarrhea) can lead to dehydration, which may injure the kidneys
Maintenance Phase After the initial series, you can taper down to a maintenance schedule
Semaglutide is administered as a once-weekly injection, making it easy to incorporate into your routine